Delivery Order SPE2DX22D0059-SPE2D825F0BWP

Award Date 12/16/24
Potential Completion Date 12/17/24
Potential Value $16K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DX22D0059
    Indefinite Delivery Contract
  • SPE2DX22D0059-SPE2D825F0BWP
    Delivery Order

This federal contract award, valued at $15,738.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order (DO) under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the supply of a variety of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and test kits. The contract has a period of performance through December 17, 2024 and was awarded on December 16, 2022 without any set-aside designation, indicating open competition. Amerisourcebergen's extensive IDC with the DLA, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for providing a comprehensive range of critical medical commodities to support military healthcare programs globally.

Generated 3/17/25, 9:45 AM